Effects of calcium carbonate, magnesium oxide and sodium citrate bicarbonate health supplements on the urinary risk factors for kidney stone formation

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 1, 2003, Pages 39-45

  Allie, Shameez ^a   Rodgers, Allens ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Calcium dietary supplements; Citrate dietary supplements; Magnesium dietary supplements; Urinary risk factors

Indexed keywords

BICARBONATE; CALCIUM; CALCIUM CARBONATE; CALCIUM PHOSPHATE DIBASIC; CHLORIDE; CITRATE SODIUM; CITRIC ACID; CREATININE; MAGNESIUM; MAGNESIUM OXIDE; OXALIC ACID; PHOSPHATE; POTASSIUM; SODIUM; URIC ACID;

ADULT; ARTICLE; CALCIUM OXALATE STONE; CALCIUM STONE; CHEMICAL INTERACTION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DRUG EXCRETION; DRUG POTENTIATION; HUMAN; HUMAN EXPERIMENT; MALE; NEPHROLITHIASIS; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; URIC ACID STONE; URINALYSIS; URINARY EXCRETION; URINE PH;

ADULT; ANTACIDS; CALCIUM CARBONATE; CITRATES; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; DRUG SYNERGISM; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY CALCULI; MAGNESIUM OXIDE; MALE; RISK FACTORS; SODIUM BICARBONATE;

EID: 0037217193     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.008     Document Type: Article

References (32)

1. Pak CYC, Fuller C, Sakhaee K, Preminger GM, Britton F. Long-term treatment ofcalcium nephrolithiasis with potassium citrate. J Urol 1985; 134:11-9.
2. Pak CYC. Citrate and renal calculi: an update. Miner Electrolyte Metab 1994; 20:371-7.
3. Ettinger B, Pak CYC, Citron JT. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 1997; 158:2069-73.
4. Whalley NA, Meyers AM, Martins M, Margolius LP. Longterm effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia. Br J Urol 1996; 78:10-4.
5. Berg C. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation. J Urol 1992; 148:979-85.
6. Purich DL, Antinozzi P, Brown CM. Inhibitory action of citrate on calcium oxalate monohydrate crystal nucleation and growth. Proceedings of the VIIth International Symposium on Urolithiasis Australia 1992: 155-7.
7. Kok DJ, Papapoulos SE, Bijvoet OLM. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet 1986; 1:1056-8.
8. Ogawa Y. Impact of sodium potassium citrate on the diurnal variations in urinary calcium oxalate and calcium phosphate saturation levels in normal individuals. Br J Urol 1994; 73:136-41.
9. Ito H. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers. Clin Nephrol 1992; 37:14-8.
10. Sakhaee K. Limited risk of kidney stone formation during long term calcium citrate supplementation in non-stone forming subjects. J Urol 1994; 152:324-7.
11. Levine B. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for prevention of osteoporosis. Am J Clin Nutr 1994; 60:592-6.
12. Pak CYC. Physicochemical action of potassium magnesium citrate in nephrolithiasis. J Bone Min Res 1992; 7:281-5.
13. Schwille PO. Acute oral calcium-sodium citrate load in healthy males. Effects on acid-base and mineral metabolism, oxalate and other risk factors of stone formation in urine. Meth Find Exp Clin Pharmacol 1997, 19:417-27.
14. Bataille P, Charransol G, Gegoire I. Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones. J Urol 1983; 130:218-23.
15. Curhan GC, Willett CW, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Eng J Med 1993; 328:833-8.
16. Massey LK, Smith HR, Sutton RL. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones. J Am Diet Assoc 1993; 93:901-6.
17. Barilla DE, Notz C, Kennedy D, Pak CYC. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciuria: effect of calcium and magnesium. Am J Med 1978; 64:576-85.
18. Berg W, Bothor C, Pirlich W, Janitzky V. Influence of magnesium on the absorption and excretion of calcium and oxalate ions. Eur Urol 1986; 12:274-82.
19. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Internal Med 1997; 126:497-504.
20. Langenhoven MJ, Kruger M, Gouw E, Faber M. MRC Food composition tables, 3rd ed. Cape Town: South African Medical Research Council, 1991.
21. Werness PG, Brown CM, Smith LH, Finlayson B. EQUIL 2: a basic computer programme for the calculation of urinary saturation. J Urol 1985; 134:1242-4.
22. Lewandowski S, Rodgers A, Schloss I. The influence of a high-oxalate/low-calcium diet on calcium oxalate renal stone risk factors in non-stone-forming black and white South African subjects. Br J Urol Int 2001; 87:307-11.
23. Sakhaee K, Nicar M, Hill K, Pak CYC. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int 1983; 24:348-52.
24. Muldowney FP, Freaney R, Moloney MF. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 1982; 22:292-6.
25. Martini LA, Cuppari L, Cunha MA, Schor N, Heilberg IH. Potassium and sodium intake and excretion in calcium stone forming patients. J Renal Nutr 1998; 8: 127-31.
26. Breslau NA, Heller HJ, Reza-Albarran AA, Pak CYC. Physiological effect of slow release potassium phosphate for absorptive hypercalciuria: a randomized double-blind trial. J Urol 1998; 160:664-8.
27. Domrongkitchaiporn S, Ongphiphadhanakul B, Stitchantrakul W. Risk of calcium oxalate nephrolithiasis after calcium or combined calcium and calcitriol supplementation in postmenopausal women. Osteoporos Int 2000; 11:486-92.
28. Fetner CD, Barilla DE, Townsend J. Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis. J Urol 1978; 120:399-401.
29. Johansson G, Backman U, Danielson BG, Fellstrom B, Ljunghall S, Wikstrom B. Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol 1980; 124:770-3.
30. Pak CYC, Chu S. A simple technique for the determination of urinary state of saturation with respect to brushite. Invest Urol 1973; 11:211-5.
31. Ryall RL, Marshall VR. The investigation and management of idiopathic uroloithiasis. In: Wickham JEA, Buck AC, editors. Renal tract stone metabolic basis and clinical practice. Edinburgh: Churchill Livingstone, 1990:307-31.
32. Hesse A, Classen A, Knoll M, Timmermann F, Vahlensieck W. Dependence of urine composition on the age and sex of healthy subjects. Clin Chim Acta 1986; 160:79-86.